URMC Research Network

Find People
Last Name
More Search Options

Mohamedtaki Tejani

TitleAssistant Professor
InstitutionSchool of Medicine and Dentistry
AddressUniversity of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester NY 14642
Other Positions
TitleAssistant Professor
InstitutionUniversity of Rochester Medical Center
DepartmentCancer Center

 Awards And Honors
2006     Johnson & Johnson International Health Elective
2000 - 2004Woodruff Simpson Fellowship  | Graduate Study in Medicine
2011     Participant, AACR Workshop  | On Molecular Biology in Clinical Oncology
2003     DIHG Fellowship  | for research
Dr. Tejani received his Bachelor of Arts degree, Magna Cum Laude, from Amherst College in Amherst, Massachusetts. He later earned his medical degree from Dartmouth Medical School in Hanover, Hew Hampshire.

From 2004 to 2008, Dr.Tejani completed his residency and held the position of chief resident at Yale-New Haven Hospital in New Haven, Connecticut. Prior to joining
Wilmot Cancer Center, he was a fellow in hematology/oncology at Fox Chase Cancer Center/Temple University in Philadelphia, Pennsylvania.

Dr. Tejani is certified by the American Board of Internal Medicine and is licensed to practice medicine in the state of New York. He is a member of professional organizations including ASCO (American Society of Clinical Oncology) and AACR (American Association of Cancer Research).

In addition to being the recipient of several awards, Dr. Tejani has authored numerous oncology-related publications. Dr. Tejani's research experience and areas of interest include gastrointestinal cancers, head and neck cancer, communication and the culture of medicine. Dr. Tejani firmly believes that patient care is a privilege. Listening and responding to a patient's unique story is critical in helping that family on their cancer journey. Originally from Tanzania (East Africa), he is fluent in Swahili, Hindi, Urdu and Gujrati.

 Selected Publications
List All   |   Timeline
  1. Tejani MA, Saif MW. Pancreatic neuroendocrine tumors: does chemotherapy work? JOP. 2014; 15(2):132-4.
    View in: PubMed
  2. Kamen C, Tejani MA, Chandwani K, Janelsins M, Peoples AR, Roscoe JA, Morrow GR. Anticipatory nausea and vomiting due to chemotherapy. Eur J Pharmacol. 2014 Jan 5; 722:172-9.
    View in: PubMed
  3. Tejani MA, Galloway TJ, Lango M, Ridge JA, von Mehren M. Head and neck sarcomas: a comprehensive cancer center experience. Cancers (Basel). 2013; 5(3):890-900.
    View in: PubMed
  4. Janelsins MC, Tejani MA, Kamen C, Peoples AR, Mustian KM, Morrow GR. Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients. Expert Opin Pharmacother. 2013 Apr; 14(6):757-66.
    View in: PubMed
  5. Gewandter JS, Fan L, Magnuson A, Mustian K, Peppone L, Heckler C, Hopkins J, Tejani M, Morrow GR, Mohile SG. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer. 2013 Jul; 21(7):2059-66.
    View in: PubMed
  6. Tejani MA, Burtness BA. Multi-modality therapy for cancer of the esophagus and GE junction. Curr Treat Options Oncol. 2012 Sep; 13(3):390-402.
    View in: PubMed
  7. Tejani MA, Cohen RB, Mehra R. The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer. Biologics. 2010; 4:173-85.
    View in: PubMed
  8. Saif MW, Tejani MA. Safety of capecitabine use in patients with liver dysfunction. Clin Adv Hematol Oncol. 2007 Sep; 5(9):730-2; discussion 736.
    View in: PubMed


Tejani's Networks

Similar People
Same Department